| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 405 | NB100-305AF405 | |||
| Alexa Fluor 488 | NB100-305AF488 | |||
| Alexa Fluor 647 | NB100-305AF647 | |||
| Alexa Fluor 700 | NB100-305AF700 | |||
| Biotin | NB100-305B | |||
| DyLight 405 | NB100-305V | |||
| DyLight 488 | NB100-305G | |||
| DyLight 550 | NB100-305R | |||
| DyLight 650 | NB100-305C | |||
| FITC | NB100-305F | |||
| HRP | NB100-305H | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF457-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF366-SP | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 350 | IC457U-100UG | |||
| Alexa Fluor 405 | IC457V-100UG | |||
| Alexa Fluor 488 | IC457G-100UG | |||
| Alexa Fluor 594 | IC457T-100UG | |||
| Alexa Fluor 647 | IC457R-100UG | |||
| Alexa Fluor 700 | IC457N-100UG | |||
| Alexa Fluor 750 | IC457S-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB457-SP | |||
| Carrier Free | MAB457-500 | |||
| Carrier Free | IC457V-100UG | |||
| Carrier Free | IC457U-100UG | |||
| Carrier Free | IC457T-100UG | |||
| Carrier Free | IC457S-100UG | |||
| Carrier Free | IC457R-100UG | |||
| Carrier Free | IC457N-100UG | |||
| Carrier Free | IC457G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB366-SP | |||
![Immunocytochemistry/Immunofluorescence: 53BP1 Antibody [NB100-305] - HeLa cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X TBS + 0.5% Triton-X100. The cells were incubated at a 1:200 dilution overnight at 4C and detected with and anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Alpha tubulin was used as a co-stain at a 1:1000 dilution and detected with and anti-mouse Dylight 550 (Red) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize2/53BP1-Antibody-Immunocytochemistry-Immunofluorescence-NB100-305-img0003.jpg "Immunocytochemistry/Immunofluorescence: 53BP1 Antibody [NB100-305] - HeLa cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X TBS + 0.5% Triton-X100. The cells were incubated at a 1:200 dilution overnight at 4C and detected with and anti-rabbit Dylight 488 (Green) at a 1:500 dilution. Alpha tubulin was used as a co-stain at a 1:1000 dilution and detected with and anti-mouse Dylight 550 (Red) at a 1:500 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.")
![Western Blot: 53BP1 Antibody [NB100-305] - Sample: Whole cell lysate (20 ug/lane) from U2Os cells resolved on a 3 to 8 percent trisacetate gel.](http://images.novusbio.com/fullsize2/53BP1-Antibody-Western-Blot-NB100-305-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: 53BP1 Antibody [NB100-305] - Analysis in HeLa cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize2/53BP1-Antibody-Immunocytochemistry-Immunofluorescence-NB100-305-img0002.jpg)
![Immunohistochemistry: 53BP1 Antibody [NB100-305] - Placenta, Villi 40X](http://images.novusbio.com/fullsize2/53BP1-Antibody-Immunohistochemistry-NB100-305-img0005.jpg)
![Western Blot: CCL21/6Ckine Antibody [NBP2-37928] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG. Lane 4: Human Plasma. Lane 5: Human liver tissue. Lane 6: Human tonsil tissue](http://images.novusbio.com/fullsize2/CCL21-6Ckine-Antibody-Western-Blot-NBP2-37928-img0002.jpg "Western Blot: CCL21/6Ckine Antibody [NBP2-37928] - Lane 1: Marker [kDa] 250, 130, 95, 72, 55, 36, 28, 17, 10. Lane 2: Human cell line RT-4. Lane 3: Human cell line U-251MG. Lane 4: Human Plasma. Lane 5: Human liver tissue. Lane 6: Human tonsil tissue")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining in human lymph node and cerebral cortex tissues using anti-CCL21 antibody. Corresponding CCL21 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize2/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0006.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human cerebral cortex shows low expression as expected.](http://images.novusbio.com/fullsize2/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0004.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody [NBP2-37928] - Staining of human lymph node shows high expression.](http://images.novusbio.com/fullsize2/CCL21-6Ckine-Antibody-Immunohistochemistry-Paraffin-NBP2-37928-img0005.jpg)
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize2/CCL21-6Ckine-Antibody-(MM0146-2H26)-Immunohistochemistry-Paraffin-NBP2-12103-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (MM0146-2H26) [NBP2-12103] - 4% PFA fixed and parffine embedded human placental tissue section (4um) is subjected to IHC staining. Tissue was treated with 15ug/ml Protenase K for antige retrieval before IHC is applied.")
![Western Blot: CCL21/6Ckine Antibody [H00006366-B01P] - Analysis of CCL21 expression in transfected 293T cell line by CCL21 polyclonal antibody. Lane 1: CCL21 transfected lysate(14.74 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize2/CCL21-6Ckine Antibody-Western Blot-H00006366-B01P-img0001.jpg "Western Blot: CCL21/6Ckine Antibody [H00006366-B01P] - Analysis of CCL21 expression in transfected 293T cell line by CCL21 polyclonal antibody. Lane 1: CCL21 transfected lysate(14.74 KDa). Lane 2: Non-transfected lysate.")
![Western Blot: CCL21/6Ckine Antibody [H00006366-D01P] - Analysis of CCL21 expression in transfected 293T cell line by CCL21 polyclonal antibody.Lane 1: CCL21 transfected lysate(14.60 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize2/CCL21-6Ckine Antibody-Western Blot-H00006366-D01P-img0002.jpg "Western Blot: CCL21/6Ckine Antibody [H00006366-D01P] - Analysis of CCL21 expression in transfected 293T cell line by CCL21 polyclonal antibody.Lane 1: CCL21 transfected lysate(14.60 KDa).Lane 2: Non-transfected lysate.")
![Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104](http://images.novusbio.com/fullsize2/CCL21-6Ckine Antibody (RM0174-10K10)-Immunohistochemistry-Paraffin-NBP2-12104-img0001.jpg "Immunohistochemistry-Paraffin: CCL21/6Ckine Antibody (RM0174-10K10) [NBP2-12104] - The Kidney tissue samples from the Folic Acid induced kidney injury model were fixed using 4% PFA at 4C for overnight and embeded in paraffin. 4um section was sublected to IHC with NBP2-12104")